Dec 14 (Reuters) - The U.S. Food and Drug Administration on
Wednesday said it approved Pfizer Inc's ointment to
treat mild to moderate cases of the itchy skin condition eczema,
or atopic dermatitis, for use in patients aged two years and
older.
Read more
No comments:
Post a Comment